CME Outfitters Announces Live psychCME TV Activity: "Reducing Relapse: Case-Based Strategies for Achieving Successful Long-Term Outcomes in Patients with Schizophrenia"
CME Outfitters, LLC, announces an upcoming live and interactive CE activity titled "Reducing Relapse: Case-Based Strategies for Achieving Successful Long-Term Outcomes in Patients with Schizophrenia." Offered as a live satellite broadcast, webcast, and telephone audioconference premiering Wednesday, August 10, 2005, from 12:00 p.m.–1:00 p.m. ET, the activity will focus on providing case- and evidence-based educational information regarding the neurochemical basis of relapse in schizophrenia and offering novel strategies for reducing and preventing relapse.
Rockville, MD (PRWEB) July 12, 2005 -- CME Outfitters, LLC, nationally
accredited provider of multidisciplinary medical education programming and
related healthcare communications services, is pleased to announce an upcoming
live and interactive CE activity titled "Reducing Relapse: Case-Based Strategies
for Achieving Successful Long-Term Outcomes in Patients with Schizophrenia."
Offered as a live satellite broadcast, webcast, and telephone audioconference
premiering Wednesday, August 10, 2005, from 12:00 p.m.–1:00 p.m. ET, the
activity will focus on providing case- and evidence-based educational
information regarding the neurochemical basis of relapse in schizophrenia and
offering novel strategies for reducing and preventing relapse. The recorded
satellite broadcast will re-air from 3:00 p.m.–4:00 p.m. ET. This CE activity
will be available as an archived webcast, podcast, and telephone audioconference
shortly after the live broadcast, and available as a videotape or multimedia
CD-ROM in September.
Participation in this activity is free, as is
obtaining a CE certificate; however, registration is required. Three forms of
registration are accepted:
Fax: View the activity details page at http://www.psychCME.net/cmea.asp?ID=119, print and complete
the activity details form, and fax to 240.243.1033
Online: Visit the
psychCME TV page at http://www.psychCME.net
Phone: Call 877.CME.PROS
(877.263.7767)
Statement of Need:
Schizophrenia is a severe,
debilitating mental illness characterized by a progressive decline in a
patient’s functioning and relationship with the outside world. Although some
patients recover, the risk for relapse after a schizophrenic episode remains
elevated throughout the patient’s lifetime. Moreover, the risk for chronicity
increases with every relapse. Therefore, one of the main goals of treatment is
more effective reduction of relapse and recurrence. Studies show that atypical
antipsychotics have advantages in preventing relapse of schizophrenia compared
with the conventional antipsychotics in first episode patients, and even among
previously stable, nonremitted patients. Many of these patients achieve symptom
remission with significant improvements in multiple symptom domains and
patient-rated health status after switching to atypical antipsychotics with
assured compliance. Several neurotransmitter systems have been implicated in the
neurobiology of schizophrenia, including dopamine, glutamate, serotonin, and
norepinephrine. This case-based psychCME TV activity will explore the
neurobiology of relapse in schizophrenia, define parameters that contribute to
relapse, and offer novel interventions to reduce and prevent relapse and improve
long-term functional outcomes.
psychCME Chair and Moderator:
Prakash
S. Masand, MD
Consulting Professor of Psychiatry
Duke University Medical
Center
Durham, NC
Faculty:
John M. Kane, MD
Chairman, Department
of Psychiatry
The Zucker Hillside Hospital
Professor of Psychiatry,
Neurology, and Neuroscience
Albert Einstein College of Medicine
Glen Oaks,
NY
Robert R. Conley, MD
Chief, Treatment Research
Maryland
Psychiatric Research Center
Professor of Psychiatry and Pharmacy
Science
University of Maryland School of Medicine
Baltimore,
MD
Learning Objectives:
At the end of this CE activity, participants
should be able to:
- Identify the neurochemical basis of relapse in
schizophrenia
- Describe the long-term clinical implications of preventing
relapse
- Discuss novel pharmacologic strategies in preventing relapse in
patients with schizophrenia
Target Audience:
Physicians, physician
assistants, nurse practitioners, nurses, psychologists, social workers,
certified case managers, pharmacists, and other healthcare professionals with an
interest in mental health.
Commercial Support:
CME Outfitters, LLC,
gratefully acknowledges an educational grant from Janssen Pharmaceutica in
support of this CE activity.
Credit Information:
psychCME offers
credit for the widest variety of clinicians compared to other broadcast CE
series. This psychCME activity offers SIX types of CE credit:
1. Physicians
(ACCME/AMA PRA Category 1)
2. Nurses (ANCC)
3. Pharmacists (ACPE)
4.
Psychologists (APA)
5. Social Workers (NASW)
6. Certified Case Managers
(CCMC)
For complete activity details and CE credit information, visit the
psychCME TV page at http://www.psychcme.net
About CME Outfitters:
CME
Outfitters is a full service healthcare communications agency providing
continuing education content development, production, marketing, accreditation,
and project management services to the healthcare industry. Among its many
collaborative ventures, CME Outfitters enjoys an exclusive role in producing,
certifying, and supporting the popular psychCME series of educational activities
originally developed at Duke University Medical Center. For more information on
CME Outfitters, including a complete calendar of its free award-winning
educational activities, please visit http://www.cmeoutfitters.com, or call 877.CME.PROS
(877.263.7767).
CME Outfitters' weekly e-newsletter, psychCME EXTRA, is a
convenient way to stay informed of all CME Outfitters news and information. To
subscribe, visit http://www.cmeoutfitters.com and click on "Register for
Updates."
Contact: Christopher Perez
CME Outfitters,
LLC
240.243.1303 direct
240.243.1033 fax
# # #
Source : http://www.prweb.com/releases/2005/7/prweb259922.htm